Mirum Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €852.85M +17.6% €232.55M +79.1% 27.3% +0.094 pp N/A N/A
    (estimated) €725.03M +18.6% €129.83M +114.4% 17.9% +0.080 pp N/A N/A
    (estimated) €611.23M +18.2% €60.56M +3,014.0% 9.9% +0.095 pp €194.04M +38.7% 31.7% +0.047 pp
    (estimated) €517.01M +19.8% €1.94M -106.6% 0.4% +0.072 pp €139.88M +124.7% 27.1% +0.13 pp
    (estimated) €431.39M +50.1% -€29.36M -60.9% -6.8% +0.19 pp €62.27M +545.0% 14.4% +0.11 pp
    €287.35M +80.8% -€75.01M -46.2% -26.1% +0.62 pp €9.65M -122.3% 3.4% +0.31 pp
    €158.97M +141.8% -€139.39M +20.5% -87.7% +0.88 pp -€43.36M -57.6% -27.3% +1.3 pp
    €65.73M +302.7% -€115.72M +61.5% -176.0% +2.6 pp -€102.23M +5.4% -155.5% +4.4 pp
    €16.32M +∞% -€71.64M -18.7% -438.9% -4.4 pp -€97.01M +28.0% -594.3% -5.9 pp
    €0.00 +NaN% -€88.08M +96.5% N/A -€75.78M +127.3% N/A
    €0.00 +NaN% -€44.83M +202.9% N/A -€33.33M -648.4% N/A
    €0.00 -€14.80M N/A €6.08M N/A

    Notifications